Paul Tudor Jones’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-212,489
Closed -$4.08M 3494
2026
Q1
$3.74M Buy
+212,489
New +$4.27M 0.01% 1371
2025
Q4
Sell
-273,010
Closed -$4.76M 3449
2025
Q3
$4.76M Sell
273,010
-865,720
-76% -$12.8M 0.01% 1224
2025
Q2
$15.9M Buy
1,138,730
+761,272
+202% +$12.3M 0.03% 432
2025
Q1
$7.03M Buy
377,458
+2,055
+0.5% +$30.6K 0.02% 634
2024
Q4
$4.22M Sell
375,403
-64,379
-15% -$753K 0.02% 793
2024
Q3
$5.2M Buy
439,782
+4,424
+1% +$41.8K 0.02% 685
2024
Q2
$3.4M Buy
435,358
+1,383
+0.3% +$9.03K 0.02% 811
2024
Q1
$2.15M Buy
433,975
+239,599
+123% +$1.53M 0.01% 984
2023
Q4
$1.67M Buy
194,376
+70,616
+57% +$517K 0.01% 1189
2023
Q3
$859K Sell
123,760
-3,936
-3% -$23.7K 0.01% 1381
2023
Q2
$734K Buy
+127,696
New +$826K 0.01% 1499
2022
Q4
Sell
-141,265
Closed -$1.67M 2327
2022
Q3
$1.67M Buy
+141,265
New +$2.06M 0.04% 617
2022
Q1
Sell
-21,332
Closed -$300K 1952
2021
Q4
$300K Buy
+21,332
New +$374K 0.01% 1844
2021
Q2
Sell
-99,600
Closed -$2.18M 1577
2021
Q1
$2.18M Buy
+99,600
New +$1.95M 0.04% 489

Other funds holding ALHC

Paul Tudor Jones's ALHC Position: Q2 2026 in Review

Paul Tudor Jones sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 212,489 shares — an estimated $4.08M sold.

Paul Tudor Jones first reported a position in ALHC in Q1 2021 and held it in 14 quarters. The position peaked at $15.9M in Q2 2025. 321 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Paul Tudor Jones reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 212,489 Alignment Healthcare shares in Q2 2026, an estimated $4.08M.
  • Paul Tudor Jones first reported a position in Alignment Healthcare in Q1 2021 and held it in 14 quarters.
  • Paul Tudor Jones's Alignment Healthcare position peaked at $15.9M in Q2 2025.
  • 321 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.